A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer’s Disease
出版年份 2021 全文链接
标题
A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer’s Disease
作者
关键词
-
出版物
JOURNAL OF ALZHEIMERS DISEASE
Volume 85, Issue 2, Pages 485-501
出版商
IOS Press
发表日期
2021-11-24
DOI
10.3233/jad-210612
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Dysbiosis and Alzheimer’s Disease: Cause or Treatment Opportunity?
- (2021) Manuel H. Janeiro et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far?
- (2021) Karen Salve Coutinho-Wolino et al. EUROPEAN JOURNAL OF NUTRITION
- Magnesium in Aging, Health and Diseases
- (2021) Mario Barbagallo et al. Nutrients
- Alzheimer’s Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical Models
- (2021) Maria Jose Carranza-Naval et al. Biomolecules
- Young at Gut—Turning Back the Clock with the Gut Microbiome
- (2021) Harish Narasimhan et al. Microorganisms
- Mitochondrial Dysfunction and Mitophagy Closely Cooperate in Neurological Deficits Associated with Alzheimer’s Disease and Type 2 Diabetes
- (2021) Sangita Paul et al. MOLECULAR NEUROBIOLOGY
- Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms
- (2021) Zenghui Wei et al. Frontiers in Neuroscience
- Reassessment of Pioglitazone for Alzheimer’s Disease
- (2021) Ann M. Saunders et al. Frontiers in Neuroscience
- Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders
- (2021) Qian Chen et al. Frontiers in Pharmacology
- Liraglutide Protects Against Brain Amyloid-β1–42 Accumulation in Female Mice with Early Alzheimer’s Disease-Like Pathology by Partially Rescuing Oxidative/Nitrosative Stress and Inflammation
- (2020) Ana I. Duarte et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Alzheimer’s Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies
- (2020) Jonathan Chang-Cheng Shieh et al. MOLECULAR NEUROBIOLOGY
- Shared Causal Paths underlying Alzheimer’s dementia and Type 2 Diabetes
- (2020) Zixin Hu et al. Scientific Reports
- The novel GLP‐1/GIP analogue DA5‐CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD
- (2020) Cheng Li et al. Brain and Behavior
- Role of Insulin Resistance in the Alzheimer's Disease Progression
- (2020) Thuy Trang Nguyen et al. NEUROCHEMICAL RESEARCH
- Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer's disease
- (2020) Ansab Akhtar et al. NEUROCHEMISTRY INTERNATIONAL
- Can dipeptidyl peptidase-4 inhibitors treat cognitive disorders?
- (2020) Qi Cheng et al. PHARMACOLOGY & THERAPEUTICS
- Dietary Supplementation with Curcumin Reduce Circulating Levels of Glycogen Synthase Kinase-3β and Islet Amyloid Polypeptide in Adults with High Risk of Type 2 Diabetes and Alzheimer’s Disease
- (2020) Rohith N Thota et al. Nutrients
- Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes
- (2020) Carmen Hierro-Bujalance et al. Alzheimers Research & Therapy
- Islet Amyloid Polypeptide: A Partner in Crime With Aβ in the Pathology of Alzheimer's Disease
- (2020) Ana F. Raimundo et al. Frontiers in Molecular Neuroscience
- The role of mitochondrial-related nuclear genes in age-related common disease
- (2020) Huanzheng Li et al. MITOCHONDRION
- Glycogen synthase kinase-3: The missing link to aberrant circuit function in disorders of cognitive dysfunction?
- (2020) Joshua D. Manduca et al. PHARMACOLOGICAL RESEARCH
- Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia
- (2020) Suzanne Craft et al. JAMA Neurology
- Link between Diabetes and Alzheimer’s Disease Due to the Shared Amyloid Aggregation and Deposition Involving Both Neurodegenerative Changes and Neurovascular Damages
- (2020) Gabriela Dumitrita Stanciu et al. Journal of Clinical Medicine
- Shared signaling pathways in Alzheimer’s and metabolic disease may point to new treatment approaches
- (2020) Jahnavi Suresh et al. FEBS Journal
- Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease
- (2020) Denisa Margină et al. FOOD AND CHEMICAL TOXICOLOGY
- Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration
- (2020) Francesco Gentile et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Alzheimer’s disease and type 2 diabetes mellitus: A systematic review of proteomic studies
- (2020) Jessica Diniz Pereira et al. JOURNAL OF NEUROCHEMISTRY
- Insulin resistance: a connecting link between Alzheimer’s disease and metabolic disorder
- (2020) Viplav Kshirsagar et al. METABOLIC BRAIN DISEASE
- The Other Side of Alzheimer’s Disease: Influence of Metabolic Disorder Features for Novel Diagnostic Biomarkers
- (2020) Chiara Argentati et al. Journal of Personalized Medicine
- Enhancement of select cognitive domains with rosiglitazone implicates dorsal hippocampus circuitry sensitive to PPARγ agonism in an Alzheimer's mouse model
- (2020) IbDanelo Cortez et al. Brain and Behavior
- Genetic Variants behind Cardiovascular Diseases and Dementia
- (2020) Wei-Min Ho et al. Genes
- Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development
- (2019) Zeba Mueed et al. Frontiers in Neuroscience
- Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer’s disease
- (2019) Gifty M. Jojo et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β
- (2019) Mei Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
- (2019) Grazia Daniela Femminella et al. Trials
- Mitochondrial Dysfunctions: A Thread Sewing Together Alzheimer’s Disease, Diabetes, and Obesity
- (2019) Giulia Rigotto et al. Oxidative Medicine and Cellular Longevity
- Exenatide alleviates mitochondrial dysfunction and cognitive impairment in the 5×FAD mouse model of Alzheimer’s disease
- (2019) Jingjing An et al. BEHAVIOURAL BRAIN RESEARCH
- A pilot study of exenatide actions in Alzheimer’s disease
- (2019) Roger J. Mullins et al. Current Alzheimer Research
- Investigating the Relationship Between Type 2 Diabetes and Dementia Using Electronic Medical Records in the GoDARTS Bioresource
- (2019) Alex S.F. Doney et al. DIABETES CARE
- Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies
- (2019) Mei Xue et al. AGEING RESEARCH REVIEWS
- A systematic literature review of the effect of insulin sensitizers on the cognitive symptoms of Alzheimer’s Disease in transgenic mice
- (2019) Amy Craig et al. BEHAVIOURAL BRAIN RESEARCH
- A Systematic Review of Meta-Analyses that Evaluate Risk Factors for Dementia to Evaluate the Quantity, Quality, and Global Representativeness of Evidence
- (2019) Kaarin J. Anstey et al. JOURNAL OF ALZHEIMERS DISEASE
- DPP-4 inhibitor improves learning and memory deficits and AD-like neurodegeneration by modulating the GLP-1 signaling
- (2019) Shuyi Chen et al. NEUROPHARMACOLOGY
- Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease
- (2018) Hong-Yan Cai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice
- (2018) Zhenri Ou et al. BRAIN BEHAVIOR AND IMMUNITY
- Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease
- (2018) Jingjing Tai et al. BRAIN RESEARCH
- DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease
- (2018) Yue Cao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Conundrum of GSK3 Inhibitors: Is it the Dawn of a New Beginning?
- (2018) Ratan V. Bhat et al. JOURNAL OF ALZHEIMERS DISEASE
- Sweet Mitochondria: A Shortcut to Alzheimer’s Disease
- (2018) Paula I. Moreira JOURNAL OF ALZHEIMERS DISEASE
- Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer’s Disease
- (2018) P. Hemachandra Reddy et al. JOURNAL OF ALZHEIMERS DISEASE
- The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease
- (2018) Andre F Batista et al. JOURNAL OF PATHOLOGY
- New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer’s Disease
- (2018) Kai Long Zhong et al. METABOLIC BRAIN DISEASE
- Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
- (2018) Geert Jan Biessels et al. Nature Reviews Endocrinology
- Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
- (2018) Steven E. Arnold et al. Nature Reviews Neurology
- Review: Relationship of type 2 diabetes to human brain pathology
- (2018) J. J. Pruzin et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Reduced brain insulin signaling: A seminal process in Alzheimer's disease pathogenesis
- (2018) George S. Bloom et al. NEUROPHARMACOLOGY
- Impaired peripheral glucose homeostasis and Alzheimer's disease
- (2018) Nadeeja Wijesekara et al. NEUROPHARMACOLOGY
- Evidence for altered insulin receptor signaling in Alzheimer's disease
- (2018) Chelsea M. Griffith et al. NEUROPHARMACOLOGY
- Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets
- (2018) Marcelo N.N. Vieira et al. NEUROPHARMACOLOGY
- Predicting dementia from primary care records: A systematic review and meta-analysis
- (2018) Elizabeth Ford et al. PLoS One
- Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits
- (2018) Shreyasi Chatterjee et al. Frontiers in Neuroscience
- Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review
- (2018) Christian Benedict et al. Frontiers in Neuroscience
- Alzheimer's disease and Type 2 Diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline
- (2018) Yevgen Chornenkyy et al. BRAIN PATHOLOGY
- Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis
- (2018) Jared M. Campbell et al. JOURNAL OF ALZHEIMERS DISEASE
- Neural correlates of liraglutide effects in persons at risk for Alzheimer’s disease
- (2018) Kathleen T. Watson et al. BEHAVIOURAL BRAIN RESEARCH
- Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology
- (2018) Martina Holubová et al. NEUROPHARMACOLOGY
- Insulin Resistance in Alzheimer's Disease
- (2018) Laís S. S. Ferreira et al. Frontiers in Neuroscience
- Impact of Metabolic Syndrome on Neuroinflammation and the Blood–Brain Barrier
- (2018) Peter Van Dyken et al. Frontiers in Neuroscience
- Sitagliptin protects the cognition function of the Alzheimer’s disease mice through activating glucagon-like peptide-1 and BDNF-TrkB signalings
- (2018) Qing Dong et al. NEUROSCIENCE LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More